Basic Information
Fampyra
Regulatory Information
EMEA/H/C/002097
Authorised
July 20, 2011
18
January 14, 2025
Company Information
Ireland
10 Earlsfort Terrace Dublin 2, D02 T380
ACORDA THERAPEUTICS IRELAND LIMITED
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Fampyra is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (Expanded Disability Status Scale 4-7).
Overview Summary
This is a summary of the European public assessment report (EPAR) for Fampyra. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Fampyra. For practical information about using Fampyra, patients should read the package leaflet or contact their doctor or pharmacist.